Best TWAS P=1.34e-08 · Best GWAS P=3.76e-08 conditioned to 0.179
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | RPS26 | 0.48 | 0.62 | lasso | 5 | 0.63 | 5.9e-99 | -5.3 | -5.2 | 2.1e-07 | 0.88 | 0.00 | 0.99 | FALSE |
2 | GTEx | Artery Tibial | SUOX | 0.18 | 0.14 | enet | 23 | 0.18 | 2.1e-14 | -4.7 | 5.4 | 5.9e-08 | -0.85 | 0.04 | 0.96 | FALSE |
3 | GTEx | Artery Tibial | RPS26 | 0.07 | 0.02 | enet | 5 | 0.01 | 3.5e-02 | -5.3 | -5.4 | 8.2e-08 | 0.93 | 0.01 | 0.97 | FALSE |
4 | GTEx | Cells Transformed fibroblasts | RPS26 | 0.11 | 0.08 | enet | 15 | 0.09 | 3.4e-07 | -5.1 | -5.4 | 6.6e-08 | 0.85 | 0.02 | 0.98 | FALSE |
5 | GTEx | Colon Transverse | SUOX | 0.24 | 0.22 | enet | 24 | 0.25 | 3.8e-12 | -4.6 | 5.2 | 1.7e-07 | -0.77 | 0.02 | 0.98 | FALSE |
6 | GTEx | Nerve Tibial | RPS26 | 0.12 | 0.09 | enet | 7 | 0.11 | 3.0e-08 | -5.5 | -5.5 | 3.6e-08 | 0.95 | 0.00 | 1.00 | FALSE |
7 | GTEx | Ovary | RPS26 | 0.50 | 0.24 | enet | 25 | 0.22 | 5.0e-06 | -5.0 | -5.7 | 1.3e-08 | 0.84 | 0.01 | 0.98 | TRUE |
8 | METSIM | Adipose | RPS26 | 0.30 | 0.40 | lasso | 5 | 0.41 | 7.2e-66 | -5.1 | -5.2 | 1.9e-07 | 0.90 | 0.01 | 0.99 | FALSE |
9 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | RPS26 | 0.14 | 0.22 | lasso | 2 | 0.23 | 4.8e-19 | -5.1 | -5.2 | 1.9e-07 | 0.90 | 0.01 | 0.99 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | RPS26 | 0.30 | 0.44 | enet | 10 | 0.45 | 5.2e-104 | -5.3 | -5.2 | 1.5e-07 | 0.90 | 0.00 | 0.99 | FALSE |
11 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | RPS26 | 0.23 | 0.40 | lasso | 2 | 0.39 | 1.5e-20 | -5.3 | -5.2 | 2.4e-07 | 0.88 | 0.01 | 0.99 | FALSE |
12 | The Cancer Genome Atlas | Colon Adenocarcinoma | RPS26 | 0.43 | 0.48 | lasso | 4 | 0.47 | 1.8e-30 | -5.3 | -5.1 | 2.9e-07 | 0.88 | 0.00 | 0.99 | FALSE |
13 | The Cancer Genome Atlas | Esophageal Carcinoma | RPS26 | 0.19 | 0.13 | lasso | 5 | 0.11 | 2.4e-04 | -5.3 | -5.2 | 2.2e-07 | 0.88 | 0.01 | 0.96 | FALSE |
14 | The Cancer Genome Atlas | Glioblastoma Multiforme | RPS26 | 0.41 | 0.38 | enet | 9 | 0.39 | 7.9e-13 | -5.1 | -5.2 | 2.1e-07 | 0.91 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | RPS26 | 0.17 | 0.29 | lasso | 4 | 0.29 | 6.2e-33 | -5.1 | -5.3 | 1.3e-07 | 0.91 | 0.01 | 0.99 | FALSE |
16 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | RPS26 | 0.27 | 0.38 | enet | 8 | 0.40 | 5.0e-24 | -5.3 | -5.1 | 2.8e-07 | 0.90 | 0.01 | 0.99 | FALSE |
17 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | RPS26 | 0.18 | 0.31 | lasso | 2 | 0.29 | 3.9e-14 | -5.3 | -5.3 | 1.5e-07 | 0.88 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | RPS26 | 0.22 | 0.31 | lasso | 3 | 0.31 | 1.6e-35 | -5.3 | -5.2 | 2.2e-07 | 0.90 | 0.00 | 0.99 | FALSE |
19 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | RPS26 | 0.36 | 0.44 | lasso | 7 | 0.42 | 2.4e-19 | -5.1 | -5.2 | 1.6e-07 | 0.92 | 0.01 | 0.98 | FALSE |
20 | The Cancer Genome Atlas | Rectum Adenocarcinoma | RPS26 | 0.24 | 0.18 | lasso | 2 | 0.20 | 1.9e-05 | -5.3 | -5.1 | 2.9e-07 | 0.88 | 0.01 | 0.92 | FALSE |
21 | The Cancer Genome Atlas | Soft Tissue Sarcoma | RPS26 | 0.23 | 0.31 | lasso | 3 | 0.30 | 2.4e-18 | -5.3 | -5.2 | 1.9e-07 | 0.88 | 0.00 | 0.99 | FALSE |
22 | The Cancer Genome Atlas | Stomach Adenocarcinoma | RPS26 | 0.19 | 0.32 | lasso | 5 | 0.34 | 2.0e-25 | -5.1 | -5.2 | 2.1e-07 | 0.89 | 0.01 | 0.99 | FALSE |
23 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | RPS26 | 0.46 | 0.64 | lasso | 4 | 0.65 | 8.5e-30 | -5.3 | -5.2 | 2.5e-07 | 0.89 | 0.01 | 0.99 | FALSE |